C12N 2770/32022
New viral proteins or individual genes, new structural or functional aspects of
Official title: New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
C12N2770/32022 (New viral proteins or individual genes, new structural or functional aspects of) appears on 37 US grants and 63 published applications in this corpus.
Search patents in C12N- Granted patents
- 37
- Published applications
- 63
- Assignees
- 38
- Inventors
- 142
- Latest grant
- 6 Jan 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2002 | 1 | 0 |
| 2003 | 1 | 2 |
| 2004 | 0 | 1 |
| 2005 | 0 | 2 |
| 2006 | 2 | 2 |
| 2007 | 2 | 2 |
| 2008 | 0 | 1 |
| 2009 | 1 | 1 |
| 2010 | 1 | 3 |
| 2011 | 1 | 2 |
| 2012 | 0 | 2 |
| 2013 | 0 | 1 |
| 2014 | 2 | 1 |
| 2015 | 2 | 1 |
| 2016 | 2 | 3 |
| 2017 | 1 | 0 |
| 2018 | 0 | 4 |
| 2019 | 2 | 3 |
| 2020 | 4 | 6 |
| 2021 | 1 | 3 |
| 2022 | 2 | 5 |
| 2023 | 4 | 5 |
| 2024 | 5 | 5 |
| 2025 | 2 | 7 |
| 2026 | 1 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Senecavirus A virus strains and immunogenic compositions therefrom6 Jan 2026US 12,514,917 B2South Dakota Board of Regents
- Oncolytic virus expressing a car T cell target and uses thereof22 Jul 2025US 12,364,724 B2City of Hope
- Cancer immunotherapy using virus particles8 Jul 2025US 12,350,326 B2Case Western Reserve University
- Pseudotyped insect baculovirus gene transfer system and pseudotyped baculovirus for shrimps, construction method and use thereof8 Oct 2024US 12,110,497 B2Ocean University of China
- Recombinant nucleic acid molecule based on point mutation of translation initiation element and use thereof in preparation of circular RNA6 Aug 2024US 12,054,722 B2Purecodon (Hong Kong) Biopharma Ltd.
- Oncolytic Viruses as Therapeutic Agents for Treating Cancer6 Aug 2026US 2026/0226426 A1ImmVirX Pty Ltd
- Oncolytic virus expressing a car t cell target and uses thereof18 Dec 2025US 2025/0381237 A1City of Hope
- Novel regulatory element for enhancing rna stability or mrna translation, zcchc2 interacting therewith, and use thereof3 Jul 2025US 2025/0215440 A1Institute for Basic Science
- Method for screening regulatory element for increasing mrna translation, novel regulatory element resulting from method, and use thereof15 May 2025US 2025/0154500 A1Institute for Basic Science
- Viral Vaccines27 Mar 2025US 2025/0101066 A1
Most cited
By later US patents
- Method for producing non-infectious recombinant picornavirus particles8US 6,440,718 B1november Aktiengesellschaft Gesellschaft fur Molekulare Medizin · 2002
- Picornaviruses, vaccines and diagnostic kits5US 7,101,554 B2Microtus AB · 2006
- Seneca Valley virus based compositions and methods for treating disease5US 7,638,318 B2Norvartis AG · 2009
- Grapevine fanleaf virus resistance in grapevine4US 7,211,710 B2Cornell Research Foundation, Inc. · 2007
- Seneca Valley virus based compositions and methods for treating disease4US 8,039,606 B2Novartis AG · 2011